LNA-ISH Cytogenetics - Human centromere alpha satelliteISH probes from Exiqon
Description:Exiqons LNA technology enables sensitive, fast and specific detection of chromosomal sequences directly on intact chromosomes. Related Conte...MutaPLATE Listeria monocytogenes from Alpco Diagnostics
Description:Screening assay to detect the Listeria monocytogenes in food samples byDNA amplification and molecular hybridization on a microtiter plate....Two-dimensional Optimization of a Semi-nested PCR for Detecting Listeria monocytogenes
for Detecting Listeria monocytogenes Andrea Tanzer, Institute of Milk Hygiene, Milk Technology and Food Science, Austria Christian Rohrer, Eppendorf AG, Germany Introductio...Use of the DCode System to Detect the Food-Borne Bacterial Pathogen Listeria monocytogenes
Nikolaj Schmolker, Fintan van Ommen Kloeke and Gill Geesey, Departmentof Microbiology and Center for Biofilm Engineering, Montana State University,Bozeman, MT 59717-3980 Amplification of a region of the 16S rRNA gene of L. monocytogenes, Listeria innocua, and Listeria seeligeri by the polymerase chain reac...Cytogenetics, High Resolution & Fragile X DNA
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting
CHICAGO--(BUSINESS WIRE)--Jun 4, 2007 - Cytogen Corporation(NASDAQ: CYTO) today reported results from clinical trialsdemonstrating that QUADRAMET (samarium Sm-153 lexidronam injection)can be safely administered to prostate cancer patients who are alsoreceiving the chemotherapy docetaxel (Taxotere(R), Sanofi-Aventis).Clinical data also support further evaluation of the combinationregimen for...Cytogen Reports Publication Validating the Utility of its Proprietary ProChart Database
PRINCETON, N.J.--(BUSINESS WIRE)--May 23, 2007 - CytogenCorporation (NASDAQ: CYTO) today reported the publication of areview validating the utility of its ProChart(TM) database to helpdefine the function of the WW domain-containing oxidoreductase(WWOX), an important tumor suppressor gene with known involvementin breast, prostate, lung, pancreatic, esophageal, and gastriccancers. The peer-re...CytoGenix to Present at 2007 International DNA Vaccines Conference in Spain
HOUSTON--(BUSINESS WIRE)--May 23, 2007 - CytoGenix, Inc. (CYGX.OB)announced today that Dr. Yin Chen, Chief Scientific Officer willpresent an update on preclinical animal data for DNA vaccines madeusing the Company's proprietary synDNA(TM) technology at the 2007DNA Vaccines conference to be held in Malaga, Spain between May 23and May 25. Dr. Chen comments, "We have successfully conducted t...